Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not really sure what the deal is...I am just ready for Summus to take off...and MAYBE this is the beginning!
Great deal for sure!
I am pumped about the timing...Dan did it in a very nice TIME TABLE this time around!
I'm LOL too, since I own SMMW, nice deal.
Do the investors get cash for it, what does Dan pay for the assets ? Transparency rules lol
Nope............wasn't me. I thought they would close.
Need a new shell to RM into.
Whatever inconsequential nothings Dan didn't want, I'd imagine. Nice closed LOI, hey was it you saying it wouldn't get closed just two days ago when the PR was released? LMAO!!!
Lemmi guess.....the scraps would be the 100m in sales over 3 years.
All the assets SMMW desired, left the scraps to the BPMT investors. Done deal. Nice LOI close. Dan is the man.
Ya......ok.........substantially all the assets.
SUN VALLEY, Calif., Aug. 13, 2007 (PRIME NEWSWIRE) -- Summus Works, Inc. (Pink Sheets:SMMW) announced the Company has closed its acquisition of substantially all the assets and business operations of BioPharmetics, Inc. (Pinksheets:BPMT). All definitive agreements pertinent to the acquisition have been executed and approved by the company.
great info...thanks
Summus Works, Inc. (Pink Sheets:SMMW) announced the Company has successfully acquired substantially all the assets and business operations of BioPharmetics, Inc. .........
The acquisition remains subject to the execution of definitive agreements and approvals. The closing date and further information will be released publicly.
Huh????????
They did or they didn't.
SUN VALLEY, Calif., Aug 13, 2007 (PrimeNewswire via COMTEX News Network) --
Summus Works, Inc. (Pink Sheets:SMMW) announced the Company has successfully acquired substantially all the assets and business operations of BioPharmetics, Inc. (Pink Sheets:BPMT).
Three subsidiary divisions of BioPharmetics, Inc. provide quality durable medical equipment, diabetic supplies, and health, beauty, and anti-aging products to customer in the U.S., Canada, and over 23 countries throughout the world. The largest -- the pharmaceutical division -- distributes medical equipment and diabetes supplies, and dispenses physician-prescribed medications through its pharmacy partners. Additionally, the division works closely with a dealer network of health care companies and managed care facilities to provide superior pricing and customer support for Medicare, Medi-Cal, Medicaid and private insurance reimbursement programs.
The Biotechnology division is available for clients wanting to manufacture and test potential prescription medications and assist to facilitate the necessary FDA clinical trials in order to gain approval.
The cosmetic division manages the distribution of the TOMA line of cosmetics as well as private label manufacturing for companies seeking to enter the market place with their own formulations and ideas. BioPharmetics, Inc. was founded in 2005 and is headquartered in Sun Valley, CA.
The acquisition remains subject to the execution of definitive agreements and approvals. The closing date and further information will be released publicly.
For more information visit http://www.biopharmetics.com.
The BioPharmetics, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4096
The Summus Works, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4093
This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
LOL...I just read the PR now! I was just responding to some messages...WOW!
I am trying to get relaxed...I am SLOW! And want to see a PR!
That soon enough for you? It's time to relax.
Is that what you are predicting? Have you heard something that leans that way?
Great product..BUT is that part of the Assets that SMMW is going to aquire?
Yeah HAM is great at advertising...I think it is all coming together for sure!
not to mention again wonder who could do the advertising for them
those are nice can be hook to you computor to send results strait to doctors
For further information on the Eclipse(TM) Blood Glucose Monitoring System and pricing, please call 877-819-8701 XT 245
SUN VALLEY, CA--(MARKET WIRE)--Jun 13, 2007 -- BioPharmetics, Inc. (Other OTC:BPMT.PK - News) announced today that they have signed a distribution agreement to market and sell the Eclipse Glucose Monitoring System for HMD BioMedical, a leading manufacturer of Telemedicine products. The Eclipse Glucose Monitoring System is the first of its kind in the U.S.
BioPharmetics enters telemedicine, the future of health care, with Eclipse blood glucose monitoring system
Sun Valley 13 June 2007BioPharmetics Inc. has signed a distribution agreement to market and sell the Eclipse Glucose Monitoring System for HMD BioMedical, a manufacturer of telemedicine products. The Eclipse Glucose Monitoring System is the first of its kind in the United States.
I would love to see a list of their assets. But I have not been able to piece one together!
I like the sounds of that better...I am TRYING not to disappoint myself...LOL! Not asking too much, you know what I mean? Reverse Psycology?
Would you settle for the completed LOI PR? And more following that?
I am with you...give us a PR stating WHEN the LOI is going to be completed!
Buying their assets, hoping we see the pr stating completed the LOI and has purchased assets as pr'd...etc
TwinTrader Alliances
Alliances:
If you have a company interested in utilizing the premier investor communication service on the internet, please let us know. We focus on working with intermediaries, affiliates and partners towards creating mutually beneficial and profitable win-win situations. We consider all proposals of joint ventures, alliances and affiliations and work fervently through collaboration and teamwork. We firmly believe that if one is willing to refer valuable, quality clients to us – we treat their referrals as our own.
If you are in the group below, please contact us. We look forward to working with you.
Reverse Merger Firms
Investor Relations Firms
Public Relations Firms
Investment Advisors/Stockbrokers
Money Managers
Hedge Fund Managers
Accounting/Consulting Firms
Law Firms/Attorneys
Merger & Acquisition Firms
Investment Banks
Equity Syndicate Departments
Similar Website Affiliates
Stock Promotions (6-11-2007)
This is the date of that $6000 compensation...very interesting! I am sure they KNEW at this time, that this company's ASSETS were being looked at by a buyer?
http://news.moneycentral.msn.com/provider/providerarticle.aspx?Feed=MW&Date=20070611&ID=7016...
BioPharmetics, Inc. (PINKSHEETS: BPMT) announced that Value Providers Inc, one of the largest manufacturers of Durable Medical Equipment sold in the U.S., has made a significant investment into BioPharmetics.
Under the terms of this investment, BioPharmetics will now become the exclusive distributor on all current and future VPI product lines to include Medicare reimbursed products such as wheelchairs, walkers, and various other home and healthcare products throughout the U.S., its territories and the United Kingdom. In addition, BioPharmetics will assume full responsibility to manage sales through a network of 500 dealers throughout the U.S.
BioPharmetics, Inc. (BPMT) previously at $0.068 up 10% at $0.075 with 35,772 shares traded. (BPMT) was highlighted today by Twin Trader
BioPharmetics, Inc. announced today that they have signed a distribution agreement to market and sell the Eclipse Glucose Monitoring System for HMD BioMedical. The Eclipse Glucose Monitoring System is the first of its kind in the U.S., and can be coupled with the Eocene Modem, allowing patients to upload their glucose levels via telephone to a secure server accessed only by authorized physicians and insurance companies. BioPharmetics, Inc. press has been in short supply until Monday's announcement that Value Providers Inc. has made a significant investment into BioPharmetics. BioPharmetics will now become the exclusive distributor on all current and future VPI product lines. BioPharmetics will also assume full responsibility to manage sales through a network of 500 dealers. This move could bode well for (BPMT) which projects the investment could increase BioPharmetics sales to over $20 million per year. Mr. Paul D. Lisenby, CEO of BioPharmetics, Inc. stated "This could have an impact on our revenues to potentially see the company reach close to $100 million in sales over the next 36 months."
BioPharmetics, Inc. engages in the manufacture and distribution of pharmaceutical, cosmetic, and anti-aging products.
The land of the UNknown is what makes investing so much fun!
This is very interesting isnt it...lol Never know what comes up next.
thanks Max for sharing that...
Over $5m written off...that was an expensive deal! I guess that means the company is REAL...heck if they were NOT, they would have never recieved financing for $5m worth of products?
Already filled by Max. I think he will do great at it!
I think egor should get that spot......
Annual Report date: Mar 31, 2007
RELEASED: Jun 24, 2007
http://www.pinksheets.com/otciq/ajax/showFinancialReportById?id=11000
Investor Relations:
Shareholder Information
Exchange - Pink Sheets
Stock Price Information - BCSM.PK
Transfer Agent
Island Transfer
100 First Ave., Suite 212
St. Petersburg, FL 33701
PH: (727) 287-1512 Fax: (727) 287-1612
Carl Dilley
carl@islandstocktransfer.com
Investor Relations
Core Consulting Group
2019 Novato Blvd
Novato, CA 94947
P: 925-465-6088
Fax – 925-281-9704
Mr. Paul Deriso
Email: paul@coreconsultingroup.com
Nope you are the man...congrats Max!
Hey,are you keeping that last moderator spot open for Mountnman.lol
Are you guys joined at the hips.
lol
BioPharmetics, Inc. Announces Stock Symbol Change to "BPMT"
Market Wire, March, 2006
BioPharmetics, Inc. (OTC: BCSM), is pleased to announce, in conjunction with our forward stock split, that effective at the opening of trading on Monday April 3, the common shares of the Company will begin trading under the symbol "BPMT."
For more information about all of BioPharmetics, Inc. products, please visit the website at www.biopharmetics.com
About BioPharmetics, Inc. (OTC: BCSM)
BioPharmetics, Inc., formerly known as BTG Cosmetics, Inc., is a manufacturer and distributor of quality pharmaceutical, cosmetic, and anti-aging products. The company has three divisions: biotechnology, pharmaceuticals, and cosmetics/cosmeceuticals, working in unison to develop, manufacture, and distribute, high-quality products in the retail, wholesale, and professional markets. Brands currently offered include Toma(TM), Isseo(TM), Molo Africa(TM), Micha(TM), and Natural Angel(TM). BioPharmetics, Inc., also private labels many brands of cosmetics and Cosmeceuticals for salons and retail stores as well as compounding specialized prescriptions for doctors nationwide.
For information on BioPharmetics, Inc. visit their website at www.biopharmetics.net .
Key developments
BioPharmetics, Signs Strategic Alliance Agreement with Medical Cost Management
07/10/2007
BioPharmetics Inc. announced that the company has signed a strategic alliance agreement with Medical Cost Management Inc., to handle the sales and marketing to the Managed Care Companies throughout the U.S. and the U.K. Under the terms of the alliance, MCM will coordinate and oversee all sales and marketing of diabetic supplies and DME equipment to the Managed Care sector of the healthcare industry. The managed care sector represents the largest potential market throughout the U.S. and U.K. for BioPharmetics to penetrate and secure business.
BioPharmetics Signs Strategic Alliance With Universal Medical Distributors, Inc
06/18/2007
BioPharmetics Inc. announced the company has signed a strategic alliance with Universal Medical Distributors Inc. to represent the company in their sales efforts in Florida and Puerto Rico as well as working with the dealer network throughout the U.S. Under the terms of the alliance, UMDI will handle sales to Mail Order houses, Distributors, Pharmacy Chains, Nursing Home Distributors, Managed Care Organizations, Hospital Chains, Hospital Distributors and DMEs respectively. Additionally; UMDI will work closely to assist targeted Dealers and pre-qualified opportunities throughout the U.S. and P.R. who are currently in the Medicare competitive bidding process to be selected as the designated provider for their given Metropolitan Service Area (MSA).
BioPharmetics Signs Distribution Agreement with HMD BioMedical
06/13/2007
BioPharmetics Inc. announced that they have signed a distribution agreement to market and sell the Eclipse Glucose Monitoring System for HMD BioMedical. The Eclipse Glucose Monitoring System is the first of its kind in the U.S. Under the terms of the distribution agreement, BioPharmetics Inc. will have the ability to market and sell the Eclipse(TM) Blood Glucose Monitoring System. If desired, the Eclipse Meter can be coupled with the Eocene Modem, allowing patients to upload their glucose levels via telephone to a secure server accessed only by authorized physicians and insurance companies. BioPharmetics, which recently acquired 500 HME dealers through the investment of VPI into the company, will market and sell the Eclipse(TM) Meter and Eocene Modem, to HME dealers, insurance companies, and diabetic supply companies throughout the U.S. Puerto Rico, and Canada.
Company Executives:
KEY EXECUTIVES FOR BPMT*
Name Board Relationships Title Age
Paul Lisenby No Relationships Chief Executive Officer --
Ben Friedman No Relationships President --
Eugene Braddy No Relationships Chief Operating Officer
http://investing.businessweek.com/research/stocks/people/people.asp?symbol=BPMT.PK
Followers
|
6
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
234
|
Created
|
10/02/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |